BioSpace News Archive

Novel anti-metallothionein antibody, UC1MT, has the potential to become a first-in-class treatment for a range of inflammatory and autoimmune disorders

FSD Pharma Inc. is pleased to announce that construction has commenced of its heritage museum and flagship dispensary at the former Kraft plant in Cobourg, Ontario, headquarters of its wholly-owned subsidiary FV Pharma Inc.

Expansion of market position through cooperation with established company VWR in the life science sector

Axonics Modulation Technologies, Inc. announced today that it has filed an S-1 registration statement with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed public offering of its common stock.

DENARASE® is now available through VWR’s sales channels in Europe

BerGenBio ASA announces that the company and its collaborators will present interim clinical and biomarker data from its Phase II clinical programme with bemcentinib (BGB324)

Oblique Therapeutics today announced that it will present new promising preclinical data for the drug candidate OT-1096 in triple-negative breast cancer (TNBC) at the largest oncology congress in Europe, the European Society for Medical Oncology (ESMO), held 19-23 October in Munich, Germany.

Lifestyle intervention delivered in churches by community-based health workers led to a significant reduction in blood pressure among African Americans compared to health education alone, according to a study led by researchers at NYU School of Medicine publishing online October 9 in the journal Circulation: Cardiovascular Quality and Outcomes.

London area doctors can now offer exclusive, limited-membership model to patients

Dr. Small-Howard explains the mechanisms for the treatment of chronic and neuropathic pain using proprietary, cannabis-based formulations